Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 2, 2025
Adjuvant Dose-Dense Chemotherapy in Hormone Receptor-Positive Breast Cancer
Otto Metzger Filho, Karla Ballman, Jordan Campbell, et al.
Contemporary Clinical Trials
|
July 18, 2021
Effect of healthy diet and exercise on chemotherapy completion rate in women with breast cancer: The Lifestyle, Exercise and Nutrition Early after Diagnosis (LEANer) study: Study protocol for a randomized clinical trial
Tara Sanft, Maura Harrigan, Brenda Cartmel, et al.
Clinical Breast Cancer
|
January 31, 2025
Optimizing Postneoadjuvant Treatment of Residual Breast Cancer With Adjuvant Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy: A Combined Analysis of DFCI 05-055 and DFCI 09-134/TBCRC 012/ABCDE Clinical Trials
Dario Trapani, Qingchun Jin, Kathy D Miller, et al.
NPJ Breast Cancer
|
February 27, 2026
The landscape of the intestinal microbiome among patients with newly diagnosed invasive breast cancer and ductal carcinoma in situ (DCIS)
Sarah L Sammons, Thomas M Kuntz, Molly DiLullo, et al.
Journal of the National Cancer Institute
|
February 2, 2021
The Effect of Metformin vs Placebo on Sex Hormones in Canadian Cancer Trials Group MA.32
Isabel Pimentel, Bingshu E Chen, Ana Elisa Lohmann, et al.
Nature Cancer
|
February 5, 2022
Palbociclib demonstrates intracranial activity in progressive brain metastases harboring cyclin-dependent kinase pathway alterations
Priscilla K Brastianos, Albert E Kim, Nancy Wang, et al.
Nature Medicine
|
June 2, 2023
Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results
Priscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, et al.
Nature Communications
|
May 15, 2026
Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial
Ana C Garrido-Castro, Noah Graham, Katelyn X Li, et al.
Neuro-Oncology
|
December 9, 2023
Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance
Albert E Kim, Kevin W Lou, Anita Giobbie-Hurder, et al.
Biorxiv : the Preprint Server for Biology
|
September 11, 2023
Structural and functional vascular dysfunction within brain metastases is linked to pembrolizumab inefficacy
Albert E Kim, Kevin W Lou, Anita Giobbie-Hurder, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 2, 2025
Adjuvant Dose-Dense Chemotherapy in Hormone Receptor-Positive Breast Cancer
Otto Metzger Filho, Karla Ballman, Jordan Campbell, et al.
Contemporary Clinical Trials
|
July 18, 2021
Effect of healthy diet and exercise on chemotherapy completion rate in women with breast cancer: The Lifestyle, Exercise and Nutrition Early after Diagnosis (LEANer) study: Study protocol for a randomized clinical trial
Tara Sanft, Maura Harrigan, Brenda Cartmel, et al.
Clinical Breast Cancer
|
January 31, 2025
Optimizing Postneoadjuvant Treatment of Residual Breast Cancer With Adjuvant Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy: A Combined Analysis of DFCI 05-055 and DFCI 09-134/TBCRC 012/ABCDE Clinical Trials
Dario Trapani, Qingchun Jin, Kathy D Miller, et al.
NPJ Breast Cancer
|
February 27, 2026
The landscape of the intestinal microbiome among patients with newly diagnosed invasive breast cancer and ductal carcinoma in situ (DCIS)
Sarah L Sammons, Thomas M Kuntz, Molly DiLullo, et al.
Journal of the National Cancer Institute
|
February 2, 2021
The Effect of Metformin vs Placebo on Sex Hormones in Canadian Cancer Trials Group MA.32
Isabel Pimentel, Bingshu E Chen, Ana Elisa Lohmann, et al.
Nature Cancer
|
February 5, 2022
Palbociclib demonstrates intracranial activity in progressive brain metastases harboring cyclin-dependent kinase pathway alterations
Priscilla K Brastianos, Albert E Kim, Nancy Wang, et al.
Nature Medicine
|
June 2, 2023
Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results
Priscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, et al.
Nature Communications
|
May 15, 2026
Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial
Ana C Garrido-Castro, Noah Graham, Katelyn X Li, et al.
Neuro-Oncology
|
December 9, 2023
Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance
Albert E Kim, Kevin W Lou, Anita Giobbie-Hurder, et al.
Biorxiv : the Preprint Server for Biology
|
September 11, 2023
Structural and functional vascular dysfunction within brain metastases is linked to pembrolizumab inefficacy
Albert E Kim, Kevin W Lou, Anita Giobbie-Hurder, et al.
Page
of 5